Drug Profile
Teriparatide biosimilar - Zydus Cadila
Alternative Names: Teriparatide - Zydus CadilaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor type 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoporosis
Most Recent Events
- 28 Feb 2014 Launched for Osteoporosis in India (SC)